These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35753056)
1. TRIM27-USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma. Sakamoto T; Kuboki S; Furukawa K; Takayashiki T; Takano S; Yoshizumi A; Ohtsuka M Liver Int; 2023 Jan; 43(1):194-207. PubMed ID: 35753056 [TBL] [Abstract][Full Text] [Related]
2. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling. Cai J; Chen HY; Peng SJ; Meng JL; Wang Y; Zhou Y; Qian XP; Sun XY; Pang XW; Zhang Y; Zhang J FASEB J; 2018 Oct; 32(10):5238-5249. PubMed ID: 29688809 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitination-specific protease 7 enhances stemness of hepatocellular carcinoma by stabilizing basic transcription factor 3. Hu M; Dai C; Sun X; Chen Y; Xu N; Lin Z; Xu S; Cheng C; Tan Z; Bian S; Zheng W Funct Integr Genomics; 2024 Feb; 24(1):28. PubMed ID: 38340226 [TBL] [Abstract][Full Text] [Related]
4. Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma. Wang H; Zhang Y; Yan L; Lv Q; Lu J; Yun B Int J Immunopathol Pharmacol; 2022; 36():3946320221132986. PubMed ID: 36217828 [TBL] [Abstract][Full Text] [Related]
5. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3. Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090 [TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms. Wang X; Zhang Q; Wang Y; Zhuang H; Chen B Med Sci Monit; 2018 Mar; 24():1742-1750. PubMed ID: 29574466 [TBL] [Abstract][Full Text] [Related]
7. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27. Mao Y; Ding Z; Jiang M; Yuan B; Zhang Y; Zhang X Biomed J; 2022 Dec; 45(6):883-895. PubMed ID: 34974169 [TBL] [Abstract][Full Text] [Related]
8. ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1/STAT3 pathway. Tian Z; Liu Z; Fang X; Cao K; Zhang B; Wu R; Wen X; Wen Q; Shi H; Wang R Carcinogenesis; 2021 Apr; 42(3):493-506. PubMed ID: 33332531 [TBL] [Abstract][Full Text] [Related]
9. USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638. Ni W; Lin S; Bian S; Zheng W; Qu L; Fan Y; Lu C; Xiao M; Zhou P Cell Death Dis; 2020 Oct; 11(10):843. PubMed ID: 33040080 [TBL] [Abstract][Full Text] [Related]
10. LGR5 induces β-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma. Kawasaki K; Kuboki S; Furukawa K; Takayashiki T; Takano S; Ohtsuka M Liver Int; 2021 Apr; 41(4):865-881. PubMed ID: 33249719 [TBL] [Abstract][Full Text] [Related]
11. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells. Guo J; Lan Z Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247 [No Abstract] [Full Text] [Related]
12. PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway. Zhang XP; Jiang YB; Zhong CQ; Ma N; Zhang EB; Zhang F; Li JJ; Deng YZ; Wang K; Xie D; Cheng SQ Cell Physiol Biochem; 2018; 47(4):1643-1654. PubMed ID: 29945155 [TBL] [Abstract][Full Text] [Related]
13. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma. Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268 [TBL] [Abstract][Full Text] [Related]
14. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways. Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678 [TBL] [Abstract][Full Text] [Related]
15. Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation. Bian S; Ni W; Zhu M; Zhang X; Qiang Y; Zhang J; Ni Z; Shen Y; Qiu S; Song Q; Xiao M; Zheng W Int J Biol Sci; 2022; 18(3):1022-1038. PubMed ID: 35173534 [TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway. Wu Y; Yuan T; Wang WW; Ge PL; Gao ZQ; Zhang G; Tang Z; Dang XW; Zhao YF; Zhang JY; Jiang GZ Cell Physiol Biochem; 2018; 51(1):301-314. PubMed ID: 30453302 [TBL] [Abstract][Full Text] [Related]
17. Extract of Huang X; Chen Y; Zhang X; Li F; Ye H Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841 [No Abstract] [Full Text] [Related]
18. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C; Guo F; Xu G; Ma J; Shao F Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024 [TBL] [Abstract][Full Text] [Related]
19. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation. Ding H; Zhang X; Su Y; Jia C; Dai C Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532 [TBL] [Abstract][Full Text] [Related]
20. MAGED4B Promotes Glioma Progression via Inactivation of the TNF-α-induced Apoptotic Pathway by Down-regulating TRIM27 Expression. Liu C; Liu J; Shao J; Huang C; Dai X; Shen Y; Hou W; Shen Y; Yu Y Neurosci Bull; 2023 Feb; 39(2):273-291. PubMed ID: 35986882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]